BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4851506)

  • 1. Editorial: Drugs used in hyperuricaemia.
    S Afr Med J; 1974 Jun; 48(30):1278. PubMed ID: 4851506
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT
    Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
    [No Abstract]   [Full Text] [Related]  

  • 3. Should asymptomatic hyperuricaemia be treated?
    Jeremy R
    Med J Aust; 1972 Aug; 2(9):505-6. PubMed ID: 5083604
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of gout.
    Scott JT
    Br Med J; 1969 Aug; 3(5668):456-7. PubMed ID: 5811656
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Drugs used in hyperuricaemia.
    Riley MJ
    S Afr Med J; 1974 Aug; 48(42):1782. PubMed ID: 4419910
    [No Abstract]   [Full Text] [Related]  

  • 6. The Jewish Hospital of St. Louis. Therapeutic grand rounds number 7. An approach to disorders of uric acid metabolism.
    Thier SO; Wessler S; Avioli LV
    Arch Intern Med; 1974 Sep; 134(3):579-85. PubMed ID: 4855167
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs in the treatment of hyperuricemia.
    Elion GB
    Adv Nephrol Necker Hosp; 1974; 3():51-7. PubMed ID: 4219708
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of hyperuricemia].
    Gröbner W
    Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Differential indications for uricosuric drugs and allopurinol].
    Gröbner W; Zöllner N
    Klin Wochenschr; 1989 Mar; 67(5):313-5. PubMed ID: 2709742
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding hyperuricemia: nursing implications.
    Johnson ES
    Nurs Clin North Am; 1972 Jun; 7(2):399-406. PubMed ID: 4482424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic agents for gout effecting the kidney].
    Ueda Y; Kono H; Kobayashi Y; Kagawa K; Yonezawa H
    Geka Chiryo; 1970 Mar; 22(3):317-22. PubMed ID: 5467650
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug control of gout and hyperuricaemia.
    Emmerson BT
    Drugs; 1978 Aug; 16(2):158-66. PubMed ID: 352666
    [No Abstract]   [Full Text] [Related]  

  • 13. [Editorial: Therapy of gout nowadays (author's transl)].
    Mertz DP
    Schweiz Rundsch Med Prax; 1974 Oct; 63(40):1185-7. PubMed ID: 4445089
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term management of gout and hyperuricaemia.
    Scott JT
    Br Med J; 1980 Nov; 281(6249):1164-6. PubMed ID: 6775757
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of hyperuricemia in gout.
    Rastegar A; Thier SO
    Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of gout].
    Yoshimura T
    Geka Chiryo; 1970 Mar; 22(3):311-6. PubMed ID: 5467649
    [No Abstract]   [Full Text] [Related]  

  • 17. Gout and the kidney.
    Lancet; 1968 May; 1(7549):961-2. PubMed ID: 4171589
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    J Maine Med Assoc; 1979 Mar; 70(3):118-20, 122-7. PubMed ID: 374661
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug treatment of gout.
    Kelley WN; Wyngaarden JB
    Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.